Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin

Soft tissue sarcomas (STS) are a group of rare and heterogeneous cancers with few diagnostic or prognostic biomarkers. This metabolomics study aimed to identify new serum prognostic biomarkers to improve the prediction of overall survival in patients with metastatic STS. The study enrolled 24 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Miolo, Gianmaria, Di Gregorio, Emanuela, Saorin, Asia, Lombardi, Davide, Scalone, Simona, Buonadonna, Angela, Steffan, Agostino, Corona, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409362/
https://www.ncbi.nlm.nih.gov/pubmed/32708128
http://dx.doi.org/10.3390/cancers12071983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409362/
https://www.ncbi.nlm.nih.gov/pubmed/32708128
http://dx.doi.org/10.3390/cancers12071983

Ejemplares similares